Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mina

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Discovery|February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and ProgressionDaniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Nature Genetics|January 30, 2019
EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domainsMaria C Donaldson-Collier, Stephanie Sungalee, Marie Zufferey, et al.
Scientific Reports|July 17, 2015
Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cellsMarco Mina, Shigeyuki Magi, Giuseppe Jurman, et al.
Cell Reports|April 5, 2018
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome AtlasGregory P Way, Francisco Sanchez-Vega, Konnor La, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumorsDoga C Gulhan, David Barras, Marco Mina, et al.
Nature Immunology|January 22, 2019
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycleWan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Nature Immunology|March 14, 2019
Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycleWan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Oncotarget|November 18, 2015
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseSara Ceccarelli, Nadia Panera, Marco Mina, et al.
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Nature Communications|November 29, 2017
A transcribed enhancer dictates mesendoderm specification in pluripotencyMichael Alexanian, Daniel Maric, Stephen P Jenkinson, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Discovery|February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and ProgressionDaniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Nature Genetics|January 30, 2019
EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domainsMaria C Donaldson-Collier, Stephanie Sungalee, Marie Zufferey, et al.
Scientific Reports|July 17, 2015
Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cellsMarco Mina, Shigeyuki Magi, Giuseppe Jurman, et al.
Cell Reports|April 5, 2018
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome AtlasGregory P Way, Francisco Sanchez-Vega, Konnor La, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumorsDoga C Gulhan, David Barras, Marco Mina, et al.
Nature Immunology|January 22, 2019
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycleWan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Nature Immunology|March 14, 2019
Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycleWan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Oncotarget|November 18, 2015
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseSara Ceccarelli, Nadia Panera, Marco Mina, et al.
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Nature Communications|November 29, 2017
A transcribed enhancer dictates mesendoderm specification in pluripotencyMichael Alexanian, Daniel Maric, Stephen P Jenkinson, et al.
Pageof 4